(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 3.29% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.77%.
Envista Holdings's revenue in 2025 is $2,621,800,000.On average, 16 Wall Street analysts forecast NVST's revenue for 2025 to be $442,470,993,003, with the lowest NVST revenue forecast at $417,149,353,121, and the highest NVST revenue forecast at $459,242,468,769. On average, 16 Wall Street analysts forecast NVST's revenue for 2026 to be $458,913,616,303, with the lowest NVST revenue forecast at $434,414,107,586, and the highest NVST revenue forecast at $482,590,993,855.
In 2027, NVST is forecast to generate $475,027,387,137 in revenue, with the lowest revenue forecast at $452,336,566,983 and the highest revenue forecast at $502,157,715,582.